Fibroblast growth factor 21 may be a strong biomarker for renal outcomes: a meta-analysis

BACKGROUND: Fibroblast growth factor 21 (FGF21) is deemed to play an important role in kidney outcomes, while the association between FGF21 and various kidney diseases remains largely unclear and inconsistent. Therefore, we conducted this meta-analysis to find out the role of FGF21 in various renal...

Descripción completa

Detalles Bibliográficos
Autores principales: Yong, Guo, Li, Ling, Hu, Shanbiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10071947/
https://www.ncbi.nlm.nih.gov/pubmed/37009852
http://dx.doi.org/10.1080/0886022X.2023.2179336

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10071947/
https://www.ncbi.nlm.nih.gov/pubmed/37009852
http://dx.doi.org/10.1080/0886022X.2023.2179336

Ejemplares similares